Corient Private Wealth LP Makes New Investment in National HealthCare Corporation $NHC

Corient Private Wealth LP bought a new position in shares of National HealthCare Corporation (NYSEAMERICAN:NHC) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 12,430 shares of the company’s stock, valued at approximately $2,627,000.

A number of other large investors have also made changes to their positions in the stock. Mariner LLC increased its holdings in shares of National HealthCare by 0.9% in the fourth quarter. Mariner LLC now owns 6,839 shares of the company’s stock valued at $938,000 after purchasing an additional 59 shares during the last quarter. EverSource Wealth Advisors LLC boosted its stake in National HealthCare by 28.5% during the first quarter. EverSource Wealth Advisors LLC now owns 311 shares of the company’s stock worth $50,000 after buying an additional 69 shares during the last quarter. The Manufacturers Life Insurance Company boosted its stake in National HealthCare by 1.2% during the first quarter. The Manufacturers Life Insurance Company now owns 6,048 shares of the company’s stock worth $966,000 after buying an additional 70 shares during the last quarter. ProShare Advisors LLC grew its holdings in National HealthCare by 3.3% in the 4th quarter. ProShare Advisors LLC now owns 2,466 shares of the company’s stock valued at $338,000 after buying an additional 78 shares in the last quarter. Finally, Hsbc Holdings PLC grew its holdings in National HealthCare by 1.2% in the 1st quarter. Hsbc Holdings PLC now owns 7,969 shares of the company’s stock valued at $1,275,000 after buying an additional 93 shares in the last quarter. 56.44% of the stock is currently owned by hedge funds and other institutional investors.

National HealthCare Stock Performance

Shares of National HealthCare stock opened at $218.97 on Wednesday. The stock has a 50 day moving average of $220.05 and a 200 day moving average of $190.81. The firm has a market capitalization of $3.43 billion, a price-to-earnings ratio of 24.63 and a beta of 0.62. National HealthCare Corporation has a fifty-two week low of $111.24 and a fifty-two week high of $239.29.

National HealthCare (NYSEAMERICAN:NHC) last posted its earnings results on Thursday, August 6th. The company reported $1.74 EPS for the quarter. National HealthCare had a return on equity of 10.03% and a net margin of 9.00%.The company had revenue of $408.03 million for the quarter.

National HealthCare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be given a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date of this dividend is Wednesday, September 30th. National HealthCare’s dividend payout ratio (DPR) is presently 61.89%.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on NHC. The Goldman Sachs Group raised shares of National HealthCare to a “strong-buy” rating in a research report on Monday, May 18th. Royal Bank Of Canada raised shares of National HealthCare to a “hold” rating in a research note on Monday, May 18th. Robert W. Baird raised shares of National HealthCare to a “strong-buy” rating in a research note on Monday, May 18th. Finally, BMO Capital Markets upgraded shares of National HealthCare to a “hold” rating in a report on Monday, May 18th. Two research analysts have rated the stock with a Strong Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, National HealthCare presently has a consensus rating of “Buy”.

Insider Activity

In related news, Director David R. Gifford sold 1,779 shares of the business’s stock in a transaction dated Tuesday, August 25th. The shares were sold at an average price of $225.42, for a total value of $401,022.18. Following the sale, the director directly owned 1,030 shares in the company, valued at approximately $232,182.60. The trade was a 63.33% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Stephen Fowler Flatt sold 1,500 shares of the company’s stock in a transaction dated Wednesday, August 19th. The shares were sold at an average price of $237.08, for a total transaction of $355,620.00. Following the completion of the transaction, the chief executive officer directly owned 65,487 shares in the company, valued at $15,525,657.96. The trade was a 2.24% decrease in their position. The SEC filing for this sale provides additional information. 13.92% of the stock is currently owned by insiders.

National HealthCare Profile

National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.

Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.